readthroughSign in
CompanyCMMBNasdaqTel Aviv

Chemomab Therapeutics Ltd.

Chemomab Therapeutics develops nebokitug, a monoclonal antibody targeting CCL24 for immune-fibrotic diseases.

8-KNov 12Latest SEC filing
Nov 12Latest story

July 2026